Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-17-000702
Filing Date
2017-04-27
Accepted
2017-04-27 17:11:45
Documents
1
Period of Report
2017-04-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT e616079_3-ptc.html 3  
1 OWNERSHIP DOCUMENT e616079_3-ptc.xml 3 2141
  Complete submission text file 0001193805-17-000702.txt   3809
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1033 SKOKIE BOULEVARD SUITE 600 NORTHBROOK IL 60062
Business Address 1033 SKOKIE BOULEVARD SUITE 600 NORTHBROOK IL 60062 (847) 715-0606
Complete Pharma Holdings II, LLC (Reporting) CIK: 0001704768 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-35969 | Film No.: 17790212